Medicine and Dentistry
Apoplexy
100%
Anticonvulsant
50%
Biological Marker
50%
Sex Difference
50%
Burnout Syndrome
50%
Monoclonal Antibody
50%
Triptan
50%
Addictive Behavior
50%
Glucagon-Like Peptide-1 Agonist
50%
Glucagon Like Peptide 1
50%
Posterior Lumbar Interbody Fusion
50%
Emotional Stress
37%
Acute Stress
33%
Triptan Derivative
33%
Transformed Migraine
30%
Episodic Migraine
30%
Substance Use Disorder
27%
Cognition
25%
National Institutes of Health Stroke Scale
22%
Brain Ischemia
19%
Hazard Ratio
16%
Selective Serotonin Reuptake Inhibitor
16%
Reversible Cerebral Vasoconstriction Syndrome
16%
Hemiplegic Migraine
16%
Brain Infarction
13%
Pharmacogenomics
12%
Pharmacokinetic
12%
Blood Brain Barrier
12%
Metabolic Disorder
12%
Substance Abuse
12%
Species Difference
12%
Psychostimulant
12%
Insulin Resistance
12%
Dopamine Release
12%
Reperfusion Therapy
11%
Thrombectomy
11%
Magnetic Resonance Imaging
11%
Calcitonin Gene Related Peptide
10%
Radiculitis
10%
Spinal Fusion
10%
Spine Surgery
10%
Radiculopathy
10%
Mental Disorder
9%
Mortality Rate
8%
Cerebral Hemorrhage
8%
Modified Rankin Scale
8%
Transient Ischemic Attack
8%
Electric Shock
8%
Kindling Model
8%
Pentylenetetrazol
8%
Sodium Valproate
8%
Provocation Test
8%
Evidence-Based Medicine
8%
Phenobarbital
8%
Controlled Clinical Trial
8%
Medication Overuse
8%
Family Practice
8%
Pediatrician
8%
Auras
8%
Vasoconstriction
8%
Mean Arterial Pressure
7%
Physical Rehabilitation
5%
Health Care
5%
Plummer-Vinson Syndrome
5%
Rehabilitation Engineering
5%
Cross Sectional Study
5%
Blood Clot Lysis
5%
Neuroscience
Mental Disorder
83%
Longitudinal Study
50%
Headache
50%
Physical Dependence
50%
Posttraumatic Stress Disorder
50%
Mild Cognitive Impairment
50%
Anticonvulsant
50%
Phenytoin
50%
Cytochrome P450 2C9
50%
Status Epilepticus
50%
Monoclonal Antibody
50%
Glucagon-Like Peptide-1 Agonist
50%
Glucagon-Like Peptide-1
50%
Electroencephalography
16%
Psychostimulant
12%
Dopamine Release
12%
Blood Brain Barrier
12%
Migraine
10%
Neuroscience
8%
Psychiatry
8%
Valproic Acid
8%
Kindling Model
8%
Phenobarbital
8%
Pentylenetetrazol
8%
Diplopia
5%
Ataxia
5%
Dysarthria
5%
Calcitonin
5%
Pharmacology, Toxicology and Pharmaceutical Science
Anticonvulsive Agent
50%
Ovary Polycystic Disease
50%
Mild Cognitive Impairment
50%
Primary Headache
50%
Headache
50%
Prevalence
50%
Monoclonal Antibody
50%
Triptan Derivative
50%
Glucagon Like Peptide 1 Receptor Agonist
50%
Glucagon-Like Peptide-1
50%
Hemiplegic Migraine
25%
Selective Serotonin Reuptake Inhibitor
25%
Reversible Cerebral Vasoconstriction Syndrome
25%
Aneurysm
12%
Psychostimulant
12%
Drug Dependence
12%
Blood-Brain Barrier
12%
Insulin Resistance
12%
Calcitonin Gene Related Peptide
10%
Pentetrazole
8%
Phenobarbital
8%
Electric Shock
8%
Provocation Test
8%
Sodium Valproate
8%
Controlled Clinical Trial
8%
Comorbidity
7%
Focal Epilepsy
7%
Cross-Sectional Study
7%
Headache and Facial Pain
7%
Lacosamide
6%
Pregabalin
6%
Tiagabine
6%
Felbamate
6%
Vigabatrin
6%
Gabapentin
6%
Topiramate
6%
Rufinamide
6%
Levetiracetam
6%